MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 194 filers reported holding MEDICINES CO in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $22,541,000 | +140.6% | 265,373 | +41.6% | 0.14% | +122.2% |
| Q3 2019 | $9,369,000 | +67.1% | 187,373 | +21.9% | 0.06% | +40.0% |
| Q2 2019 | $5,606,000 | +231.9% | 153,713 | +154.4% | 0.04% | +200.0% |
| Q1 2019 | $1,689,000 | +53.1% | 60,413 | +4.9% | 0.02% | +66.7% |
| Q4 2018 | $1,103,000 | -18.8% | 57,613 | +26.9% | 0.01% | -10.0% |
| Q3 2018 | $1,358,000 | -11.3% | 45,413 | +8.9% | 0.01% | 0.0% |
| Q2 2018 | $1,531,000 | +11.4% | 41,717 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,374,000 | +24.7% | 41,717 | +3.5% | 0.01% | +42.9% |
| Q4 2017 | $1,102,000 | -26.2% | 40,317 | 0.0% | 0.01% | +16.7% |
| Q3 2017 | $1,493,000 | +6.6% | 40,317 | +9.5% | 0.01% | -50.0% |
| Q2 2017 | $1,400,000 | -43.1% | 36,826 | -26.8% | 0.01% | -45.5% |
| Q1 2017 | $2,461,000 | +48.2% | 50,326 | +2.9% | 0.02% | +37.5% |
| Q4 2016 | $1,661,000 | -10.0% | 48,926 | 0.0% | 0.02% | -15.8% |
| Q3 2016 | $1,846,000 | +12.2% | 48,926 | 0.0% | 0.02% | +5.6% |
| Q2 2016 | $1,645,000 | +5.9% | 48,926 | 0.0% | 0.02% | +5.9% |
| Q1 2016 | $1,554,000 | -14.9% | 48,926 | 0.0% | 0.02% | +13.3% |
| Q4 2015 | $1,827,000 | -34.5% | 48,926 | -33.5% | 0.02% | -40.0% |
| Q3 2015 | $2,791,000 | -4.7% | 73,526 | -28.1% | 0.02% | +19.0% |
| Q2 2015 | $2,928,000 | -15.3% | 102,326 | -17.1% | 0.02% | -19.2% |
| Q1 2015 | $3,458,000 | +1.6% | 123,426 | +0.3% | 0.03% | +18.2% |
| Q4 2014 | $3,405,000 | +25.1% | 123,040 | +0.9% | 0.02% | +22.2% |
| Q3 2014 | $2,722,000 | -34.4% | 121,940 | -14.6% | 0.02% | -28.0% |
| Q2 2014 | $4,148,000 | +11.8% | 142,740 | +9.4% | 0.02% | +4.2% |
| Q1 2014 | $3,709,000 | -38.3% | 130,500 | -16.1% | 0.02% | -35.1% |
| Q4 2013 | $6,009,000 | +19.3% | 155,600 | +3.5% | 0.04% | +19.4% |
| Q3 2013 | $5,038,000 | +54.8% | 150,300 | +42.1% | 0.03% | +24.0% |
| Q2 2013 | $3,254,000 | – | 105,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |